News & Views

  • Expanded Service for Irish and International Companies
    Brian Monaghan
  • Microbiology Lab, Source BioScience, Tramore Co Waterford, Ireland

Expanded Service for Irish and International Companies

Oct 17 2019 Read 530 Times

Integrated laboratory services and products provider Source BioScience, has invested €585,000 in microbiology and sterility testing labs at its facility in Tramore, Co Waterford, Ireland. The new suite of  services aim to reduce turnaround times, allowing faster customer feedback and minimisation of sample storage risks.

The company has been providing outsourced stability storage services for more than 40 years and has served the Irish market since 2007. Recently rebranded as Source Stability Storage Solutions, the Company can offer 24/7 controlled environment storage for stability trials at all World Climatic ICH conditions, as well as bespoke conditions. The investment supports the further expansion of this offering in the Irish and European markets.

Brian Monaghan, Irish Account Manager said: “This investment brings major benefits to our customers. As a core offering, it means they can safely place products within our increasing number of ICH standard storage chambers, our fully trained and experienced microbiologists can access the chambers at required time points, test the product to establish acceptable limits and notify the client, with minimum disruption to samples. We are able to maintain a single quality agreement for a number of services which represents a major upside for our clients and offers great potential for reducing lead-times including the requirement for multiple audits and minimises risk to products.”

Commercial Director Russell Wheatcroft added: “We are thrilled to bring this investment and enhanced service to our valued current and future customers in Ireland. The funding is part of a two-stage process and we now look to expand our footprint in Ireland further by increasing the capacity of our Tramore facility by 40%. The Irish market is a key element to our expected growth in Europe and this investment will be critical in driving the Company through the next phase of its development.”

Reader comments

Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.

Post a Comment




Digital Edition

International Labmate November 2019

November 2019

In This Edition Articles - Translating Proteomic MALDi Tissue Typing to Clinical Pathology - Fusion Protein Complexes Analysed by CG-MALS - The Separation and Purification of Glutamine Deri...

View all digital editions

Events

Cleanzone

Nov 19 2019 Frankfurt am Main, Germany

INCHEM TOKYO 2019

Nov 20 2019 Tokyo, Japan

Miconex

Nov 25 2019 Beijing, China

IFAT India

Dec 05 2019 New Delhi, India

Nepal Lab

Dec 13 2019 Kathmandu, Nepal

View all events